Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP562222.RAKmJVB6ECU8hCIvjIaTeQ1fC4-fOGL98fBxce6txvCeE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP562222.RAKmJVB6ECU8hCIvjIaTeQ1fC4-fOGL98fBxce6txvCeE130_assertion type Assertion NP562222.RAKmJVB6ECU8hCIvjIaTeQ1fC4-fOGL98fBxce6txvCeE130_head.
- NP562222.RAKmJVB6ECU8hCIvjIaTeQ1fC4-fOGL98fBxce6txvCeE130_assertion description "[MEF2 immunoreactivity was observed in all cases including the case of sarcoma, thus suggesting myogenic differentiation of myxoma or sarcoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562222.RAKmJVB6ECU8hCIvjIaTeQ1fC4-fOGL98fBxce6txvCeE130_provenance.
- NP562222.RAKmJVB6ECU8hCIvjIaTeQ1fC4-fOGL98fBxce6txvCeE130_assertion evidence source_evidence_literature NP562222.RAKmJVB6ECU8hCIvjIaTeQ1fC4-fOGL98fBxce6txvCeE130_provenance.
- NP562222.RAKmJVB6ECU8hCIvjIaTeQ1fC4-fOGL98fBxce6txvCeE130_assertion SIO_000772 12163362 NP562222.RAKmJVB6ECU8hCIvjIaTeQ1fC4-fOGL98fBxce6txvCeE130_provenance.
- NP562222.RAKmJVB6ECU8hCIvjIaTeQ1fC4-fOGL98fBxce6txvCeE130_assertion wasDerivedFrom befree-20140225 NP562222.RAKmJVB6ECU8hCIvjIaTeQ1fC4-fOGL98fBxce6txvCeE130_provenance.
- NP562222.RAKmJVB6ECU8hCIvjIaTeQ1fC4-fOGL98fBxce6txvCeE130_assertion wasGeneratedBy ECO_0000203 NP562222.RAKmJVB6ECU8hCIvjIaTeQ1fC4-fOGL98fBxce6txvCeE130_provenance.